CPhI Korea Launches as South Korea Commits to Extensive Drug Development Over Next 5 Years
CPhI Korea Launches as South Korea Commits to Extensive Drug Development Over Next 5 Years
PR55997
AMSTERDAM, Feb. 27, /PRN=KYODO JBN/ --
New event to accelerate and nurture South Korea's "Pharma 2020 Vision"
UBM Live has today announced the latest addition to its global pharmaceutical
events portfolio, CPhI Korea 2014, which will take place on September 2nd-3rd
2014 at the COEX in Seoul, South Korea.
(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )
South Korea is now an undisputed member of the "developed pharmaceutical
market" and home to the fastest growing industry within the developed 'league'
according to IMS Health- which reported the Country's double digit growth rate
over the last 5-years and predicted a CAGR of 6.5% until 2015. Furthermore,
South Korea is ideally located to attract key delegates and industry leaders
from Japan, China, India and Hong Kong. The event will act as a centralised hub
for regional drug manufacturers to meet with global suppliers of raw materials,
machinery, packaging solutions and contract services, as well as attracting
visitors from the region looking for suppliers and manufacturing partners to
bring cost-competitive pharmaceuticals to their individual markets.
The South Korean Government has affirmed its commitment to driving
pharmaceutical R&D and innovations, with a clear "Pharma 2020 vision". By 2020,
the country will have invested $8.9 billion into drug development, whilst
setting out clear goals and projects including open innovation through
enlargement of R&D and the collaboration of pharmaceuticals and finance to fund
the extensive drug development plans.
CPhI Korea will be co-located with ICSE for contract services, providing an
integrated platform for facilitating and encouraging the innovation and growth
plans set out by the country. The two-day event will include a conference
programme emphasising CPhI Korea's role in enabling international and domestic
business.
Highlights of CPhI Korea 2014:
Co-location with ICSE providing services and opportunities through the whole
supply chain
Conference programme featuring opinion leaders from Government, academia and
industry- with workshops, round tables and plenary sessions
A buyers programme to deliver high-value buyers in growing markets
Potential one-to-one partnering for visitors and exhibitors to provide new
leads and business partners
Chris Kilbee, Group Director, CPhI Pharma Portfolio, commented on the launch of
the event: "CPhI Korea will provide an unrivalled opportunity for
pharmaceutical industry delegates, stimulating key growth as the country
strives to develop multiple drugs over the coming years. South Korea's
commitment to R&D within the industry should be a benchmark model for other
economies to follow, particularly as the healthcare landscape continues to
rapidly change and healthcare demand is on the rise. The government support of
R&D represents a remarkable growth opportunity and the launch of CPhI Korea
will facilitate the innovations we are likely to witness as part of the
country's 5-year plan. CPhI Korea is launching at a boom time in the region
and provides an unrivalled platform for domestic and international pharma
companies to augment the next stage of development in this rapidly maturing and
dynamic market".
About CPhI
CPhI drives growth and innovation at every step of the global pharmaceutical
supply chain from drug discovery to finished dosage. Through exhibitions,
conferences and online communities, CPhI brings together more than 100,000
pharmaceutical professionals each year to network, identify business
opportunities and expand the global market. CPhI hosts events in Europe, China,
India, Japan, Korea, Southeast Asia, Istanbul, Russia and South America and
co-locates with ICSE for contract services, P-MEC for machinery, equipment &
technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI
provides an online buyer & supplier directory at CPhI-Online.com.
For more information visit: http://www.cphi.com
The UBM Live annual schedule of Pharmaceutical events also includes CPhI, ICSE,
P-MEC, BioPh and Pharmatec Japan (9-11 April, 2014 at the Big Sight Exhibition
Centre- Tokyo); CPhI Russia and IPhEB (16-17 April, 2014 at the Lenexpo
Exhibition Complex- St Petersburg, Russia); CPhI, P-MEC and Innopack South East
Asia (20-22 May, 2014 at the Jakarta International Expo- Jakarta, Indonesia);
CPhI Istanbul (4-6 June, 2014, at the Lutfi Kirdar Convention and Exhibition
Centre- Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28
June, 2014 at SNIEC- Shanghai, China); CPhI South America (5-7 August 2014 at
Expo Centre Norte, Sao Paulo- Brazil); CPhI, ICSE Korea (2-3 September, 2014 at
the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide (7-9
October 2014, Paris Nord Villepinte- France); CPhI and P-MEC India (2-4
December, 2014 at the Bombay Exhibition Centre- Mumbai).
About UBM Live
UBM Live connects people and creates opportunities for companies across five
continents to develop new business, meet customers, launch new products,
promote their brands, and expand their market. Through premier brands such as
TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete
Show, and many others, UBM Live exhibitions, conferences, awards programs,
publications, Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry sectors.
For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44(0)207-203-6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com
Source: UBM Live
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。